New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins.
about
Inflammation and haemostasisCarbon monoxide-releasing molecule-2 suppresses thrombomodulin and endothelial protein C receptor expression of human umbilical vein endothelial cells induced by lipopolysaccharide in vitro.Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities.Prehospital use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of trauma-induced coagulopathyAge-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin.Heparin oligosaccharides as potential therapeutic agents in senile dementiaThe protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implicationsMolecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblastsInflammation and thrombosis.Thrombomodulin.Current understanding of disseminated intravascular coagulation.Aetiology of Kienböck's disease.Drotrecogin alfa: a role in emergency department treatment of severe sepsis?Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge.Recombinant human activated protein C: current insights into its mechanism of actionActivation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic micePurification of a serine protease and evidence for a protein C activator from the saliva of the tick, Ixodes scapularis.Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm.Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications.Protease activated receptor-2 mediates activated protein C-induced cutaneous wound healing via inhibition of p38Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality.Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.Inactivation of thrombomodulin by ionizing radiation in a cell-free system: possible implications for radiation responses in vascular endothelium.Effects of inflammatory cytokine gene polymorphisms on warfarin maintenance doses in Korean patients with mechanical cardiac valves.Low ADAMTS-13 activity during hemorrhagic events with disseminated intravascular coagulation.Molecular challenges and viral diseases.Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation.Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression.Direct thrombin inhibitors' potential efficacy in Alzheimer's disease.Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women.Coagulation disorders in patients with cirrhosis and severe sepsis
P2860
Q26823258-AB5C0D38-CEF4-43CD-8DD8-1E76696477EFQ33760597-21F20782-C8DD-44BD-9051-81DB587B17B9Q33774895-1B70BE1D-5510-4E8F-BB47-370B3A56A815Q33896084-73097F2B-A403-4929-BB3E-948846AEFDC5Q33931868-CF3EFC9A-45DD-4727-B0D9-309AF632A163Q33965772-C714515D-30E0-4D27-B7A7-1E264F2A5D6DQ34060608-0D92A38A-0F82-485E-949A-F7A0538535C4Q34081535-D26C4C19-7ED1-4E54-AAE5-0883B2F89628Q35130879-B854799C-AB63-4A50-9DB0-1B4EBD50DA29Q35181574-5C97CAF2-90CF-4BBE-BA7F-F270E5166674Q35181628-3D4EF993-5CCB-47CD-9941-9049EE560063Q35661014-B47F4A23-E659-4C21-A3D4-B64521CF8F58Q35772938-6FA2495B-888E-4D57-B1E4-CCC77EC394D8Q35850483-03135518-8B7A-4DCF-80C3-FCEE98F560B1Q35990619-D2BC43A0-3AE8-478D-820D-881AF89D5E08Q37082968-7E8F5FA5-8457-4EA1-8990-E5567C5FA547Q37352488-484160B3-BCFF-4D8D-937C-75C8081D5457Q37423441-1D51291F-536D-4E16-A04D-E733367FDD9CQ37909137-6ADAAA6C-3625-4FA6-AEC6-11100CB04A0EQ38021497-EC419737-C44B-4BEC-BCFE-7CF52938067AQ38117276-501A4C58-6075-4F13-B17D-3E238470D33CQ38864943-7BC70DA7-613C-4B8B-82F7-69B14D08E0D9Q40404975-E9F2C2AB-86FF-4178-8D5D-E28B2879D4CDQ41504226-83240F2F-51EE-4C12-9D62-34CC0CD98790Q42759281-CB588EFD-8372-4150-90B3-A3884490F09DQ43233746-248FF05B-D347-40D9-9062-3D355FADC405Q43432297-E88573CC-B516-46BA-A6BD-25079C6DE2DEQ43839468-AE123C6C-76FA-4C63-9797-B3670D537AC8Q45872085-0EAA9144-AAA5-4AF2-8D8C-47AD92647034Q46142052-C55B91C9-BA0E-4923-BD9E-EC462824F28DQ47919792-A5236447-036F-4A4F-94B3-430250B42E3FQ48299604-7A1A148D-A870-44ED-9253-D689DFFAF7ABQ53669196-7BAE2412-AFE2-47EA-B9E0-6E8B9F2B8B1AQ58034522-3B55155E-F0B7-4FD8-A2DB-C1899C804746
P2860
New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New mechanisms for vascular co ...... atural anticoagulant proteins.
@ast
New mechanisms for vascular co ...... atural anticoagulant proteins.
@en
New mechanisms for vascular co ...... atural anticoagulant proteins.
@nl
type
label
New mechanisms for vascular co ...... atural anticoagulant proteins.
@ast
New mechanisms for vascular co ...... atural anticoagulant proteins.
@en
New mechanisms for vascular co ...... atural anticoagulant proteins.
@nl
prefLabel
New mechanisms for vascular co ...... atural anticoagulant proteins.
@ast
New mechanisms for vascular co ...... atural anticoagulant proteins.
@en
New mechanisms for vascular co ...... atural anticoagulant proteins.
@nl
P2860
P31
P921
P356
P1476
New mechanisms for vascular co ...... atural anticoagulant proteins.
@en
P2093
Charles T Esmon
P2860
P304
P356
10.1084/JEM.20021088
P407
P577
2002-09-01T00:00:00Z
2002-09-02T00:00:00Z